Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Recombinant interferon beta-1a

Known as: INTERFERON BETA-1A,RECOMBINANT, Interferon Beta-1A 
A synthetic version of naturally occurring interferons that have immunomodulatory, antiviral and antiproliferative activities. It may exert antitumor… Expand
National Institutes of Health

Related topics

Related topics

38 relations
Acquired Immunodeficiency SyndromeAge related macular degenerationAutoimmune DiseasesBrain Neoplasms
Expand

Narrower (1)

Rebif

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Interferons in the Therapy of Severe Coronavirus Infections: A Critical Analysis and Recollection of a Forgotten Therapeutic Regimen with Interferon Beta
The pharmacological and immunological properties of interferons, especially those of interferon beta, and the corresponding… Expand
2009
2009
AGE-RELATED CHANGES IN MOTOR SUBTLE SIGNS AMONG GIRLS AND BOYS WITH ADHD
Fenstermacher JD. In normal rat, intraventricularly administered insulin-like growth factor-1 is rapidly cleared from CSF with… Expand
Review
2009
Review
2009
High-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosis.
  • H. Hartung
  • Expert opinion on pharmacotherapy
  • 2009
    • Corpus ID: 30814153
BACKGROUND There is at present no cure for multiple sclerosis (MS), and existing therapies are designed primarily to prevent… Expand
2003
2003
Severe urticaria due to recombinant interferon beta‐1a
SIR, A 7-year-old boy with mild eczema was treated with Oilatum Plus (Stiefel, High Wycombe, U.K) and intermittent application of… Expand
2002
2002
Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: results of an open-label multicentre study.
Although effective conventional therapies are available to treat basal cell carcinoma (BCC), undesirable side effects, including… Expand
2000
2000
A randomized controlled trial of recombinant interferon beta-1a in ALS
Objective: To evaluate the efficacy of recombinant interferon beta (IFNβ)-1a in the treatment of ALS. Background: It has been… Expand
  • table 3
  • table 4
  • figure 4
  • figure 3
  • figure 5
2000
2000
A pilot study of recombinant interferon beta-1a for the treatment of chronic hepatitis C.
AIMS Interferon alpha monotherapy induces a sustained response in less than 20% of patients treated for chronic hepatitis C… Expand
2000
2000
A randomized controlled trial of recombinant interferon beta-1a in ALS. Italian Amyotrophic Lateral Sclerosis Study Group.
OBJECTIVE To evaluate the efficacy of recombinant interferon beta (IFNbeta)-1a in the treatment of ALS. BACKGROUND It has been… Expand
Highly Cited
1995
Highly Cited
1995
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients
The design and conduct of a randomized, double-blinded, placebo-controlled, multicenter, phase III study of recombinant… Expand
  • table 2
  • figure 1
  • table 4
  • table 5
  • table 3
1995
1995
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients…
The design and conduct of a randomized, double-blinded, placebo-controlled, multicenter, phase III study of recombinant… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE